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Abstract
Background: Rind of Punica granatum is traditionally used in treatment of abdominal cramps and various GIT
disorders. So far spasmolytic activity of rind of Punica granatum has been reported using in vitro model. However,
its mode of action is not explored yet. Therefore, the current work describes the possible mode of action for
spasmolytic activity of methanolic extract of rind of Punica granatum (Pg. Cr). Acute toxicity study is also performed
to determine its safe dose range.
Methods: Rind of Punica granatum was subjected to shade drying. Shade dried materials were pulverized using
conventional grinder. Grinded materials were macerated in commercial grade methanol. The extract of rind of P.
granatum was concentrated using a rotary evaporator. Rabbits’ jejunal preparations were mounted in organ bath
containing 10 ml Tyrode’s solution, constantly aerated with carbogen gas. Pg. Cr was tested on spontaneous
rabbits’ jejunal preparations in concentrations 0.01, 0.03, 0.1, 0.3, 1.0, 3.0, 5.0 and 10.0 mg/ml. Pg. Cr was also tested
on KCl (80 mM)-induced contractions in rabbits’ jejunal preparations. Since we observed spasmogenic activity for
the first time, hence we also determined the effects of Pg. Cr in presence of atropine (0.03 μM). Pg. Cr was also
tested in presence of 0.03 μM of loratadine HCl. Pg. Cr was also tested on barium chloride induced contractions.
Calcium Concentration Response Curves (CCRCs) were constructed in the absence and presence of test samples of
Pg. Cr in decalcified tissues to explore its possible mode of action. Acute toxicity screening was also performed to
determine its safe dose range.
Results: Phytochemical screening revealed the presence of saponins, tannins, carbohydrates, proteins, flavonoids,
saponins and steroids. However, Pg. Cr tested negative for alkaloids and triterpenoids. Pg. Cr was safe up to 100 mg/kg
with its LD50 = 1305 mg/kg. Its respective EC50, in the absence and presence of atropine, were 9.7 ± 0.3 and 3.12 ± 0.
45 mg/ml. In the presence of 0.02 and 0.08 μM of loratadine HCl, respective EC50 were 5.6 ± 0.4 and 2.8 ± 0.15 mg/ml.
EC50 for relaxant effects on KCl-induced contractions was 8.6 ± 1 mg/ml. In the presence of 0.3 mg/ml of Pg. Cr, a right
shift was observed with EC50 (log [Ca
++]M) = -1.8 ± 0.09 vs. control EC50 -2.6 ± 0.01. Similarly, EC50 for verapamil (0.1 μM)
was −2.4 ± 0.011vs. control EC50= -2.4 ± 0.01. The right shift of P. granatum resembled the right shift of verapamil
suggesting for inhibition of voltage gated calcium channels.
Conclusions: P. granatum is safe up to 100 mg/kg. In low concentrations, P. granatum produced spasmogenic activity
possibly through involvement of cholinergic and histaminergic receptors. The spasmolytic action may follow inhibition
of the voltage gated calcium channels.
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Background
Herbal medicine contributes to revenue of 2.5 $US in
countries like Japan, China, Pakistan, Sri Lanka and
Thailand [1, 2]. In general perspective, medicines of plant
origin are considered relatively safe [3]. Plant kingdom is a
rich source of bioactive molecules. For example morphine,
strychnine, cinchonine, quinine and caffeine were first
derived from plants [4]. With the passage of time, chemists
started synthesis of these molecules in laboratories. Cocaine
was synthesized by Schiff in laboratory [5]. According to a
report of WHO, more than 50% of the world population
depend on household remedies. Pharmacopoeia of the
United States describes various phyto-medicines that are
also used in Europe [6]. This strengthen the practice of
complementary and alternative medicine for the mainten-
ance of health in developing countries [7].
P. granatum is a plant that is referenced in Holy
Quran by name. It belongs to the order of Myrtales and
family of Lythraceace. More than 500 cultivators
throughout the world cultivate P. granatum [8]. It is
abundantly available in Himalayan regions and Kashmir.
It grows at an altitude of 1000–2000 m in Northern built
(South Waziristan, Khyber Pakhtun Khwa, Dir, Kurram,
Chitral and Baluchistan) of Pakistan. It is used as medi-
cine to treat obesity, arthritis and ischemia of brains [9].
More, P. granatum has anti-oxidant, anticancer and
anti-inflammatory activities [10].
Resistant strains of Bacteria like Staphylococcus aureus,
Streptococcus epidermidis, Lactobacillus acidophilus and
E.coli have shown excellent sensitivity to Punica granatum
[11]. It is also used for treatment of erectile dysfunctions
[9]. Beside oral antiseptic, it is also used to treat periodon-
titis and dental carries [9]. P. granatum has anti-diabetic
activity [8]. P. granatum is also used in treatment of skin
infections and injuries, where its role may be attributed to
its antioxidant effect [9, 10, 12]. Reported phytochemicals
of P. granatum are anthocyanins, ascorbic acid, caffeic
acid, catechin, Epigallocatechingallate (EGCG), quercetin,
sterols, punicic acid, ellagic acid, phenolic punicalagins
and flavonoids [9]. The juice of the seeds is rich in antho-
cyanins, ascorbic acid, EGCG and iron. The seed oil has
95% punicic acid, ellagic acid and sterols [9]. The leaves
are rich in tannins (punicalin and punicafolin) and fla-
vones glycosides, which include apigenin and luteolin [9].
The extract of leaves of P. granatum is used as eye washer,
as astringent for diarrhea and dysentery [13]. The rind
(peel) is rich in phenolic punicalagins, EGCG, quercetin,
rutin, flavones, flavonols, flavonones, anthocyanidins gallic
acid and other fatty acids [14]. There are reports that ex-
tract of dried rind (peel) of P. granatum is traditionally
used in stomach ache and colitis. In Indian traditional sys-
tem of medicine, P. granatum is used as an astringent,
anthelmintic, diuretic and cardio tonic [11]. As peels of P.
granatum is used in treatment of in gut spasms, therefore,
the current work is an attempt to explore its rationale on
scientific ground. More, there are studies that warrant for
search of possible rationale for use of P. granatum in gut
disorders to elucidate its mode of action [13]. Hence, we
designed the current model to elucidate possible mode of
action for spasmolytic activity of rind of P. granatum.
Methods
Collection, identification and preparation of the test
materials
Fruits of P. granatum were purchased from the Board
Bazar of Peshawar, Khyber Pakhtunkhawa. Professor Dr.
Jehandar Shah identified the plant. A voucher specimen no.
Pg-01 was submitted to the herbarium of Hakim Abdul Jalil
Herbal Research Center, Khyber Medical University, Pesha-
war. Their fleshy seeds were removed. Its rind was collected
and subjected to shade drying. We targeted the rind as it is
locally used in the treatment of gastric disorders and diar-
rhea [13]. It is called “anarsawe” in Pashtoo. The dried rind
(1.5 kg) was powdered using a conventional grinder. The
powdered materials were then soaked in commercial grade
methanol (80%) for 5 days. After 5 days, the materials were
filtered. The process was repeated thrice. The filtrates were
combined and concentrated under vacuum using a rotary
evaporator till a brownish semisolid extract, free of solvent
(20 g), was obtained. The extract was refrigerated for fur-
ther pharmacological screenings.
Preliminary phytochemical screenings
Preliminary phytochemical screenings were performed for
the presence of tannins, carbohydrates, proteins, flavo-
noids, saponins, sterols, alkaloids and triterpenoids [15, 16].
Acute toxicity study
Acute toxicity testing was performed using mice model. In
first phase, Pg. Cr was administered in test doses of 10, 100
and 1000 mg/kg (i.p) to group 1, group 2 and group 3
respectively. Each group had six mice. In second phase, 3
more groups, having 6 six mice each, were treated with
respective test doses of 1250, 1500 and 1750 mg/kg (i.p).
Death toll was noted in each group. Per cent lethality was
plotted against respective test doses. LD50 was calculated
[17, 18].
Drugs, chemicals, animals and ethical approval
All chemicals were of analytical grade. Acetylcholine was
purchased from Poole England. Rest of the chemicals
was of E. Merck grade, Germany. Double distilled water
was used in the experiments. All solutions were pre-
pared on the same day of experiments. For acute toxicity
study, Pg. Cr was re-dissolved in water for injection
(B.P.). Rabbits of either sex (average weight = 2.2 ±
0.24 kg) were purchased from the local market. Rabbits
were housed in the animal house of Institute of Basic
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Medical Sciences, Khyber Medical University, Peshawar.
Ethics Board of the Khyber Medical University in its 3rd
meeting under agenda item no. 5 approved the study
protocols on dated 8th April 2013. The protocols
complied with international standards for dealing experi-
mental animals for Scientific Procedures.
Effects on Isolated rabbits’ jejunal preparations
On spontaneous rabbits’ jejunal preparations
Rabbits were subjected to cervical dislocation. Their abdo-
mens were opened. Their jejunums were removed and
maintained in Petri dishes containing Tyrode’s solution,
constantly aerated with Carbogen gas (95% oxygen/5% car-
bon dioxide). Portions of about 1.5 cm length of rabbits’
jejunal preparations were mounted in tissue organ baths.
The tissues were stabilized in normal Tyrode’s solution for
about 30 min. Following stabilization, Pg. Cr was tested on
isolated rabbits’ jejunal preparations in concentrations 0.01,
0.03, 0.1, 0.3, 1.0, 3.0, 5.0 and 10.0 mg/ml [19–24]. Changes
in isometric tension were recorded using force transducers
(model MLT0201) coupled with bridge amplifiers FE221
connected to PowerLab 26/T (ADInstruments, Sydney,
Australia). Data was recorded using Lab Chart 7 software
(ADInstruments, Sydney, Australia). Intestinal responses
were plotted as % of control.
On spontaneous rabbits’ jejunal preparations in the
presence of cholinergic antagonists (atropine) and
histamine antagonist (loratadine)
Since Pg. Cr produced spasmogenic response in isolated
rabbits’ jejunal preparations contrary to the study pub-
lished by Qnais et al. [13]. Hence, we tried to explain the
possible mode of spasmogenic action. As intestine is
richly supplied with cholinergic and histaminergic recep-
tors, therefore, we tried Pg. Cr in similar concentrations
0.01, 0.03, 0.1, 0.3, 1.0, 3.0, 5.0 and 10.0 mg/ml in pres-
ence of cholinergic antagonist atropine (0. 03 μM)
following an incubation period of 20-25 min [25]. Pg. Cr
was also tested in similar concentrations in presence
of histamine H1 receptor antagonist loratadine HCl
(0.02 and 0.08 μM) following an incubation period of
30 min. Intestinal responses were recorded using Lab
Chart 7 Software.
Effects of Pg. Cr on KCl-induced contractions
As Pg. Cr showed relaxant effect in higher concentrations,
hence we tried to determine its possible mode of relaxation.
We tried Pg. Cr on KCl (80 mM) induced contractions.
Briefly describing, small portions of the rabbits’ jejunal
preparations were mounted in the organ baths. After
stabilization, sustained contractions were produced by
80 mM KCl (final bath solution’s strength). Pg. Cr was
applied in similar concentrations 0.01, 0.03, 0.1, 0.3, 1.0, 3.0,
5.0, 10.0 mg/ml. Intestinal responses were recorded [19].
Effect of Pg. Cr on barium chloride induced contractions
Sustained contractions in the rabbits’ jejunal prepara-
tions were produced by barium chloride (1.0 μM). Pg. Cr
was added in similar concentrations 0.01, 0.03, 0.1, 0.3,
1.0, 3.0, 5.0, 10.0 mg/ml in cumulative manner. Effects
were recorded [26].
Effects of verapamil of spontaneous and KCl-induced
contractions
Rabbits’ jejunal preparations were mounted in tissue
organ bath. After stabilizing the tissues for 30 min,
verapamil (concentration range of 0.003–3 μM) was
tested on spontaneous and KCl (80 mM)-induced con-
tractions. Effects of test samples are compared with
effects of verapamil as standard calcium channel blocker.
Effects of Pg. Cr on voltage gated calcium channels
As Pg. Cr produced a spasmolytic response; hence we con-
structed calcium chloride curves to study its effects possibly
through voltage gated channels as relaxant effects on high
molar (>60 mM) KCl induced contractions usually, but not
necessarily, imply to follow inhibition of voltage gated
calcium channels. Hence, for confirmation, we compared
the effects of Pg. Cr on calcium channels with the control
Calcium Concentration Response Curves (CCRCs) using
verapamil a standard calcium channel blocker.
For construction of CCRCs, the tissues were decalci-
fied with the Potassium Normal Tyrode’s Solution (con-
taining EDTA 0.03 g), followed by Potassium Rich
Tyrode’s solution (containing K: 3.72 g and EDTA:
0.37 g). Once decalcified, known strengths of calcium
were added and constructed the CCRCs. Curves were
constructed in range of - 4 to - 1.6 log [Ca++] M.
In other series of experiments, tissues were stabilized
in Tyrode’s solution for 30 min. The tissues were decal-
cified as described above. Pg. Cr was applied in different
concentrations with an incubation period of one hour.
CCRCs were reconstructed again in range of - 4 to - 1.6
log [Ca++] M. The process was repeated 4 times. The
CCRCs for Pg. Cr were compared with its respective
control. Similarly, control curves in presence of 0.1 μM
and 0.3 μM of verapamil were also constructed. The
CCRCs for verapamil were compared with its respective
control curves [19, 21].
Table 1 Results of acute toxicity of Punica granatum in mice
Stages Dose (mg/kg body weight, (i.p)) (n = 6 in each group)
1st stage Group1 (10 mg) Group 2 (100 mg) Group 3 (1000 mg)
Alive Alive 4 alive
2nd stage Group 1 (1250 mg) Group 2 (1500 mg) Group 3 (1750 mg)
4 died All died All died
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Statistical analysis
All data extracted from Lab Chart of Power Lab was plot-
ted for each replicate using Graph Pad Prism 7. The
response of tissues was plotted as % of its respective con-
trol. Data was analyzed at 95% CI, P ≤ 0.05 using ANOVA.
Results and discussion
Phytochemical screening revealed the presence of
tannins, carbohydrates, proteins, flavonoids, saponins and
steroids. However, Pg. Cr tested negative for alkaloids and
triterpenoids. Test for the presence of saponins was
strongly positive.
Table 1 describes the results of acute toxicity study.
Results suggest that Pg. Cr is safe up to 100 mg/kg in
test animals. Lethality started on 1000 mg/kg, where 2 of
the total 6 mice in respective group died. Similarly, 2
mice died in group1 of 2nd phase. Their % toxicity
was plotted vs. respective doses. LD50 for Pg. Cr is
1305 mg/kg (Fig. 1).
Hence, care must be taken while using its rind as trad-
itional medicine. Its dose should not be more than
100 mg/kg as it carries risks of acute toxicity.
The effect of Pg. Cr on spontaneous rabbits’ jejunal
preparations, in presence and absence of 0.03 μM atro-
pine, are shown in Fig. 2. Maximum spasmogenic
response (28 ± 1.5% of control maximum) was on 5 mg/ml.
On 10 mg/ml, spasmolytic effect was observed in absence
of atropine. However, in presence of atropine, whence the
Pg. Cr was tried in similar concentrations, spasmogenic ef-
fect was blocked. Respective EC50 values in absence and
presence of atropine are 9.7 ± 0.3 and 3.12 ± 0.45 mg/ml
(Fig. 2). This left shift in EC50 values imply for the involve-
ment of cholinergic receptors [25]. In addition to choliner-
gic receptors, GIT is rich with histaminergic receptors as
well. So we tested Pg. Cr in presence of loratadine (0.02
and 0.08 μM). In the presence of 0.02 μM and 0.08 μM of
loratadine HCl, respective EC50 are 5.6 ± 0.4 and 2.8 ±
0.15 mg/ml. Again left shift in the EC50 values suggest for
the involvement of histaminergic receptors in the spasmo-
genic response. This suggests that loratadine blocked the
spasmogenic response. Relaxant effect was observed in
higher concentrations as it was in absence of atropine
(Fig. 3). The involvement of histaminergic receptors in
spasmogenic response may be beneficial, particularly, in
indigestion where gastro-prokinetic response is sometimes
required. However, the idea of gastro-prokinetic may be
Fig. 1 Acute toxicity study of crude methanolic extract of Punica
granatum in mice
Fig. 2 Effects of crude methanolic extract of Punica granatum on spontaneous rabbits’ jejunal preparations in the presence and absence of
atropine (All values are mean ± SD, n = 3)
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further explained by designing an in vivo model to study
effects of Pg. Cr in low concentrations as our findings are
totally different than the finding of Qnais et al. (2007) [13],
where they have proven that the rind has spasmolytic activ-
ity. Perhaps relaxing effects reported by Qnais et al. (2007)
may be due to high concentration of the rind extract as Pg.
Cr relaxed the spontaneous activity in high concentration
i.e., 10 mg/ml. In an attempt to explore the possible mode
of action of relaxing effect, effects of Pg. Cr on KCl induced
and Barium chloride induced contractions are shown in
Fig. 4. EC50 for relaxant effects of Pg. Cr on KCl-induced
contractions is 8.6 ± 1 mg/ml (n = 3). It is evident that KCl
in high concentration opens the voltage gated calcium
channels and thus promotes the depolarization of tissues. A
positive relaxing effect on KCl induced contortions
suggests for the involvement of voltage gated calcium
channels [25, 27]. EC50 for effects on KCl induced
contractions is 8.6 ± 1 mg/ml. However, to rule out
the involvement of release of calcium from internal
stores, effects of Pg. Cr on barium chloride induced
contractions are also shown in Fig. 4. There is no effect of
Pg. Cr on barium chloride induced contractions, which
suggests the non-involvement of release of calcium from
internal stores [26]. These relaxing effects also resemble
the effects of verapamil on spontaneous as well as KCl-
induced contractions with EC50 of 0.34 ± 0.02 μM and
0.035 ± 0.05 μM (Fig. 5), respectively. As verapamil is a
standard calcium channel blocker that relaxed the spon-
taneous activity, hence, we used verapamil as standard
drug for effects on CCRCs. For confirmation of inhibition
of voltage gated calcium channels, effects of various
concentrations of Pg. Cr on CCRCs are shown in Fig. 6a.
Similarly, effects of verapamil on CCRCs are also shown
in Fig. 6b. In the presence of 0.3 mg/ml of Pg. Cr, the
curves gained maximum amplitude up to 70% of control
maximum. While in concentration of 1.0 mg/ml, its
Fig. 3 Effects of different concentrations of crude methanolic extract
of Punica granatum in the presence of loratadine HCl (All values are
mean ± SD, n = 3)
Fig. 4 Effects of crude methanolic extract of Punica granatum on
high concentration (80 mM) KCl-induced contractions on rabbits’
jejunal preparations and on Barium chloride induced contractions
(All values are mean ± SD, n = 3)
Fig. 5 Effects of verapamil on spontaneous as well as KCl-induced
contractions on isolated rabbits’ jejunal preparations (All values are
mean ± SD, n = 3)
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amplitude could hardly reach to 40% of control maximum
(Fig. 6a) suggesting for inhibition of voltage gated calcium
channels. Voltage gated calcium channels play a vital role
in the regulation of peristaltic movements of the intestine
as it helps in periodic depolarization and repolarization of
the muscles of gastrointestinal tract [18–22]. Since KCl
induces contractions via calcium influx from extracellular
medium to intracellular medium, hence, relaxing effects
on KCl-induced contractions may be regarded to follow
calcium channel blocking mechanisms of the voltage
gated calcium channels [21]. Pg. Cr produced a right shift
in the presence of 0.3 mg/ml with EC50 -1.8 ± 0.09 vs. con-
trol EC50 -2.6 ± 0.01 (log [Ca
++]M). Similarly, EC50 for
verapamil (0.1 μM) is −2.4 ± 0.011vs. Control EC50 -2.4 ±
0.01 (log [Ca++]M) (Fig. 6b). The right shift of Pg. Cr
resembles the right shift of Verapamil. Hence, it is
suggested that Pg. Cr may follow the inhibition of influx
of calcium through voltage gated calcium channels. The
relaxant activity may be attributed to the phytochemicals
present in Punica granatum, particularly the flavonoids
that have antispasmodic activity in general.
Conclusion
Our findings suggest that rind of Punica granatum has
spasmogenic as well as spasmolytic activity. Spasmogenic
activity may follow the involvement of histaminergic and
cholinergic receptors. However, spasmolytic activity may
follow the inhibition of voltage gated calcium channels.
The possibility of other mechanisms cannot be ruled out.
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